SPONSOR
Ambros Therapeutics, Inc.
Total Trials
2
Recruiting
2
Phases
Phase 3
Ambros Therapeutics, Inc. is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome I (CRPS I).
The trial portfolio spans Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Ambros Therapeutics, Inc.
How many clinical trials has Ambros Therapeutics, Inc. sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Ambros Therapeutics, Inc., of which 2 are actively recruiting participants. These trials cover conditions including Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome I (CRPS I). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Ambros Therapeutics, Inc. research focus on?
Ambros Therapeutics, Inc. clinical trials span Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome I (CRPS I). The research pipeline includes Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Ambros Therapeutics, Inc. clinical trial?
To participate in a Ambros Therapeutics, Inc. trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Ambros Therapeutics, Inc. trials with current recruitment status updated daily.
Clinical Trials by Ambros Therapeutics, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology